Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Anti-aging mechanisms may prevent development of Alzheimer's disease

  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Pallàs, Mercè
  • Sanfeliu, Coral
Trabajo presentado en el XI Simposi de Neurobiologia: Future technical advances, organizado por la Socitat Catalana de Biologia, en Barcelona, los días 12 y 13 de noviembre de 2018, The progressive increase in life expectancy has led to an increase in the incidence of age-related diseases, including Alzheimer’s disease (AD). Currently there are no effective treatments against AD, therefore, the search for preventive treatments is of great interest to achieve healthy aging. We hypothesize that the activation of anti-aging molecular pathways may induce a preventive effect of cellular resilience against the development of AD pathological processes. We evaluated the proposed anti-aging compounds resveratrol and melatonin by diet supplementation in 3xTgAD and control healthy NoTg mice. Both compounds activated the neuroprotective and longevity SIRT1 pathway. The changes in 3xTg-AD hippocampus included decline of Aβ and tau pathology, decrease of inflammatory markers that suggests a protection against inflammaging, increase of proteolytic mechanism against aberrant proteins, and beneficial changes in mitochondrial function and plasticity processes. Remarkably, these treatments induced upregulation of neuroprotective mechanisms in the healthy NoTg mice. Both resveratrol and melatonin protected against memory loss in 3xTg-AD and induced improved behavior in the healthy mice. Our data confirmed the potential of both anti-aging compounds to induce neuroprotection against AD-pathology, and unveiled their preventive effects by increasing brain resilience, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Monomeric C reactive protein induces signaling pathsways leaading to dementia in mice

  • García-Lara, Elisa
  • Corpas, Rubén
  • Slevin, Mark
  • Sanfeliu, Coral
Trabajo presentado en el XI Simposi de Neurobiologia: Future technical advances, organizado por la Socitat Catalana de Biologia, en Barcelona, los días 12 y 13 de noviembre de 2018, There is strong evidence that brain ischaemic processes increase the risk of suffering age-related dementia. Stroke may induce the development of vascular dementia, but also of Alzheimer’s disease (AD) which is the leading cause of dementia worldwide. Neuroinflammation derived from ischaemic damage in the vessels and brain paremchima may be the causative of neurodegeneration. We have previously demonstrated that the monomeric C- reactive protein (mCRP) may provide a causative link between stroke-associated inflammation and dementia, as its injection into the hippocampus of wild type mice induced loss of memory within one month period [Slevin et al., 2015; Sci Rep 5:13281]. mCRP is a monomeric protein that comes from the dissociation of the pentraxin C-reactive protein (CRP) that remain chronically within the extracellular matrix of ischaemic tissue after stroke. Here we reproduced the mouse model of dementia by mCRP and extended the period post injection up to 6 months to further characterize the mCRP effects on cognition and general behavior. Mice of the transgenic AD strain 5XFAD were also tested for comparison. Treatment with mCRP induced lack of learning and memory at one, three and six months after bilateral injection into the hippocampus of the mice. We assayed the hippocampus tissue for gene expression and protein levels in a search of changes underlying cognitive loss and neurodegeneration. First results revealed lower activation of signaling pathways related to Arc and Egr1 early genes in mCRP mice but not in 5XFAD mice. Main changes in 5XFAD were related to oxidative stress and gliosis markers. We will pursue the molecular study to discern differential patterns between mCRP and 5XFAD mice. Characterizing the mechanisms of mCRP-induced dementia might contribute to decrease AD incidence in the elderly., EU-COP 2014-2020, CRP-SAD, ID: P_37_674, MySMIS code: 103432, contract: 51/05.09.2016; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Resveratrol upregulates the expression of antioxidant genes inimmortalized AD lymphocytes

  • Senserrich, Júlia
  • Cosín-Tomás, Marta
  • Martín Requero, A.
  • Pallàs, Mercè
  • Kaliman, Perla
  • Sanfeliu, Coral
Trabajo presentado en el XI Simposi de Neurobiologia: Future technical advances, organizado por la Socitat Catalana de Biologia, en Barcelona, los días 12 y 13 de noviembre de 2018, Alzheimer’s disease (AD) is the most common neurodegenerative disorder and first cause of dementia all over the world. It is characterized by a progressive neuronal loss. The main risk factor for developing AD is the age. Major pathological hallmarks include extracellular deposits of amyloid protein and intracellular deposits of neurofibrillary tau protein. AD brain also shows alterations developed in aged brain such as oxidative stress and inflammation. The study used immortalized lymphocytes from patients of sporadic AD and age-matched healthy controls (HC) with the following aims: First, analyze gene expression of oxidative stress and aging-related pathways in AD and HC lymphoblast cell lines. Next, investigate the potential role of resveratrol as antiaging and protective agent through the induction of further gene expression changes. Finally, establish the different sensitivity between the human immortalized lymphocyte cell lines and the human neuroblastoma cell line SH-SY5Y to the hormetic agent resveratrol and to oxidative stress inductors. Real-time PCR showed that oxidative stress and aging-related genes were differentially expressed in AD lymphoblasts compared to HC lymphoblasts with increases in CASP1, TXNIP, VPS13C, GPX1, PRDX5, SOD2, and decrease in CCS expression. Resveratrol incubated for 18h at concentration of 10, 20 or 50µM induced a general upregulation of antioxidant and detoxifying genes such as: CAT, NFE2L2, GSTZ1, and CCS, in both HC and AD lymphoblasts. Resveratrol also induced the expression of the anti-aging mitochondrial sirtuin SIRT3. At the concentrations tested, resveratrol was not cytotoxic to lymphoblast or SH-SY5Y neuroblastoma cultures, although the later were more sensitive to oxidative injuries. This study supports that immortalized lymphocytes is a suitable cell system to analyze molecular alterations of pathways common to non-neural and neural cells. Furthermore, resveratrol upregulation of antioxidant genes may contribute to improve physiological processes in aging and AD., Supprted by grants: SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Modulation of the enzyme soluble epoxide hydrolase as a therapeutic target against neurodegenerative diseases

  • Almenara-Fuentes, Lidia
  • Corpas, Rubén
  • Suñol, Cristina
  • Vázquez, S.
  • Galdeano, Carles
  • Pallàs, Mercè
  • Sanfeliu, Coral
Trabajo presentado en el XI Simposi de Neurobiologia: Future technical advances, organizado por la Socitat Catalana de Biologia, en Barcelona, los días 12 y 13 de noviembre de 2018, Neurodegenerative diseases cursing with chronic inflammatory conditions represent a major health problem due to the global increase in life expectancy and age-related diseases. Thus, there is an urgent need for new approaches to mitigate neuroinflammation. Epoxyeicosatrienoic acids (EETs) are endogenous mediators that have several potentially protective functions including anti-inflammatory effects. EETs beneficial effects disappear when the enzyme soluble Epoxide Hydrolase (sEH) metabolizes them to the corresponding dihydroxyeicosatrienoic acids. Therefore, sEH enzyme is emerging as a promising pharmacological target, because its inhibition allows increasing EETs and keeping them active. The aim of the present study was to determine the half maximal inhibitory concentration (IC50) of a newly synthetized sEH inhibitor (sEHi) series, agents A01, A02, A03, A04, A05 and A06, and study their toxicity and anti-inflammatory effects. Neuroblastoma SH-SY5Y cell cultures were used to the IC50 calculation and the safety level of each sEHi. To study the anti-inflammatory effects, lipopolysaccharide stimulated microglial-like BV2 cells were used to obtain conditioned media with the proinflammatory mediators. Modulatory effects on the inflammatory pathways iNOS and NFĸB, and the release of cytokines were explored using techniques of Western Blot, immunocytochemistry and ELISA. All agents showed higher inhibitory potency than the reference compound 1-(1-propionylpiperidin-4-yl)- 3-[4-(trifluoromethoxy)phenyl]urea (TPPU) and generally low cytotoxicity. They also showed promising anti-inflammatory properties. In this way, the newly synthesized sEHi agents could be a new therapy against the neuroinflammation present in neurodegenerative diseases as Alzheimer’s disease, and in other neurological diseases with an inflammatory component., Supported by: SAF2016‐77703, MINECO and ERDF; 2017-SGR-106 AGAUR, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Proinsulin therapy protects against neuroinflammaging and cognitive loss in senescence-accelerated mice

  • Sanfeliu, Coral
  • Corpas, Rubén
  • Hernández-Pinto, Alberto M.
  • Porquet, David
  • Hernández-Sánchez, Catalina
  • Bosch, Fátima
  • Ortega-Aznar, Arantxa
  • Comellas, Francesc
  • De la Rosa, Enrique J.
Trabajo presentado en el IUBMB Focused Meeting on «Molecular aspects of aging and longevity», celebrado en Atenas, del 16 al 19 de octubre de 2017, Chronic low-grade neuroinflammation is tightly associated with brain age-related changes and it is considered a crucial derangement that paves the way to neurodegeneration and dementia. Among other ailments, inflammation may lead to insulin resistance that is a risk factor for Alzheimer’s disease. In this scenario, the hormone precursor proinsulin may have a potential pharmacological use in preventing neuronal death. Proinsulin is a bioactive molecule regulating neural cell death in embryonic processes and it was proven neuroprotective in mouse models of retinal neurodegeneration. We aimed to prove the geroprotective effect of a chronic proinsulin treatment against neuroinflammaging and memory loss in the senescence-accelerated mouse SAMP8. We used a gene therapy procedure through peripheral muscle transduction with an adeno-associated viral vector bearing the human proinsulin gene (AAV-hPi) that yielded sustained release of proinsulin into the bloodstream. One-month old male mice of the SAMP8 strain and the control strain SAMR1 were injected with AAV-hPi or AAV-null vectors. At 6 months of age, proinsulin-treated SAMP8 mice showed totally preserved cognitive capacities both in spatial and recognition paradigms of learning and memory, in contrast to those SAMP8 mice injected with the null vector. Hippocampus analysis showed that proinsulin activated Akt and ATF1/CREB signaling pathways in both SAMR1 and SAMP8 mice. Furthermore, we identified a significant decrease of neuroinflammatory markers in the hippocampus of SAMP8 mice to levels of SAMR1 mice. Strikingly, the marker of astrocyte reactivity GFAP was decreased in both SAMR1 and SAMP8. Furthermore, the connectome network build with all changes induced by proinsulin showed that the decrease of astrocyte reactivity was a central effect in proinsulin neuroprotection. Therefore, the preventive and protective effects of human proinsulin against neuroinflammaging and senescence-related cognitive loss unveil a potential geroprotective therapy to increase healthy brain aging., This study was supported by CSD2010-00045, SAF2016-77703-C2-2-R, MTM2014-60127-P, MINECO and ERDF; PET08-0282, TRACE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Resveratrol induces resilience against age-related neurodegeneration through improvement of proteostasis

  • Corpas, Rubén
  • Griñán-Ferré, Christian
  • Pallàs, Mercè
  • Sanfeliu, Coral
Trabajo presentado en el IUBMB Focused Meeting on «Molecular aspects of aging and longevity», celebrado en Atenas, del 16 al 19 de octubre de 2017, Resveratrol is a natural compound that mimics the antiaging effect of caloric restriction, which is mainly mediated through SIRT1, a NAD+-dependent deacetylase that induces longevity and neuroprotection by regulating the acetylation homeostasis of key proteins. Resveratrol is a potential preventive agent against age-related neurodegeneration and was proven to protect against Alzheimer’s disease (AD)-like pathology in experimental models. In this study, we aimed to analyze the effects of resveratrol on the brain status of control non-transgenic (NoTg) mice and AD transgenic mice to discern the mechanisms involved in a potential inducement of resilience against age-related neurodegeneration and AD. NoTg and 3xTg-AD mice were fed with a diet supplemented with trans-resveratrol, at 100 mg/kg during 10 month. The period of 2 to 12 months of age covered a broad period of the AD pathology progression, from the pre-symptomatic to the advanced AD pathology phase. Resveratrol administration induced complete protection against memory loss and brain pathology in 3xTg-AD mice, and also induced cognitive enhancement in NoTg mice. Resveratrol reduced the presence of Aβ and p-tau pathology in the hippocampus of 3xTg-AD mouse. Proteostasis analysis showed in both healthy and AD mice: (i) increased levels of the amyloid degrading enzyme Neprilysin; (ii) increase of protein proteasome levels and activity; (iii) reduction of the amyloidogenic secretase BACE1. Resveratrol increased the AMPK protein levels, then upregulating SIRT1 pathway as shown by activation of PGC-1α and CREB in 3xTg-AD and NoTg mice, resulting in further beneficial changes in the mitochondrial function and plasticity processes, respectively. Our data demonstrate that resveratrol induces cognitive enhancement and neuroprotection against amyloid and tau pathologies. Improvement of proteostasis by resveratrol, in both healthy and AD mice, suggests it is a mechanism of brain resilience and defense against neurodegeneration caused by accumulation of aberrant proteins., Supported by SAF2016-77703, MINECO and ERDF., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Long-term physical activity induces brain resilience in middle-aged adults

  • Corpas, Rubén
  • Solana, Elisabeth
  • Rosa, Adrián de la
  • Sarroca, Sara
  • Griñán-Ferré, Christian
  • Oriol, Mireia
  • Corbella, Emili
  • Rodríguez-Farré, Eduard
  • Vina, Jose
  • Pallàs, Mercè
  • Bartrés-Faz, David
  • Gómez-Cabrera, M. C.
  • Sanfeliu, Coral
Trabajo presentado en la Jornada Científica CIBERESP (Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública), celebrada en Madrid (España), el 14 de noviembre de 2019, AIM: Physical activity practiced regularly is known to improve the well-being and to reduce the risk of age-related diseases. We aimed to determine the impact of long-term physical activity on memory maintenance and search for peripheral blood markers related to cognitive function that may be detectable at middle-age METHODS: We performed neuropsychological analyses to veteran amateur rugby players (n = 24, age: 46–68 y) and middleaged sedentary controls (n = 25, age: 47–67 y). We analyzed the expression of selected genes in whole blood mRNA of player and control groups and young sedentary controls (n = 21, age: 17–25 y). A young trained group (n = 16, age: 18–25 y) was added to analyze age-related response in circulating neurotrophins induced by chronic exercise, Ajut Mario Sàlvia i Ferret 2014, lnstitut d'Estudis Catalans; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Long-term sport practice induces brain resilience through SIRT1-SIRT3 axis in male veteran rugby players

  • Sanfeliu, Coral
  • Corpas, Rubén
  • Solana, Elisabeth
  • Rosa, Adrián de la
  • Sarroca, Sara
  • Griñán-Ferré, Christian
  • Oriol, Mireia
  • Corbella, Emili
  • Rodríguez-Farré, Eduard
  • Vina, Jose
  • Pallàs, Mercè
  • Bartrés-Faz, David
  • Gómez-Cabrera, M. C.
Trabajo presentado en el FENS Regional Meeting, celebrado en Belgrado (Sebia), del 10 al 13 de julio de 2019, Aim: Physical exercise performed regularly is known to improve health and to reduce the risk of age-related diseases. We had previously reported improved immediate memory responses in a cohort of veteran rugby players as compared to control subjects with low physical activity. We hypothesized that long-term physically active middle-aged men have developed brain resilience that can be detected with the analysis of peripheral blood markers. Methods: We tested the expression of selected genes of longevity, inflammation, redox homeostasis, and trophic signaling in whole blood mRNA. Analyses were performed on blood samples of veteran rugby players (n=24) and controls (n=25) aged 45-65 year, and also young controls (aged 15-25 years) with low physical activity (n=21). Physical activity and other lifestyles were thoroughly recorded with standardized questionnaires. Results: Middle-aged control subjects showed lower levels of expression of SIRT1, SIRT3 and CAT than the young controls, although rugby players maintained the expression levels of these genes at a young-like level. No differences were detected in the inflammatory genes, although there was a tendency towards a decrease in trophic and transduction factors in middle-aged groups as compared to the young controls. A statistical study of Spearman’s correlations supported a positive effect of sporting activity on memory and executive functions through SIRT1, SIRT3 and antioxidant gene expression levels in the veteran rugby players. Conclusions: Our results suggest the involvement of the SIRT1-SIRT3 axis, and the downstream antioxidant and neuroprotective signaling, in the anti-aging resilience of the brain mediated by physical exercise, Ajut Mario Sàlvia i Ferret 2014, lnstitut d’Estudis Catalans; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Mechanisms of monomeric C Reactive Protein inducing neurodegeneration

  • García-Lara, Elisa
  • Aguirre Infantes, Samuel
  • Clotet Perarnau, Núria
  • Corpas, Rubén
  • Slevin, Mark
  • Sanfeliu, Coral
Trabajo presentado en el FENS Regional Meeting, celebrado en Belgrado (Sebia), del 10 al 13 de julio de 2019, AIM: Neuroinflammation derived from ischemic damage increases the risk of both vascular dementia and Alzheimer¿s disease (AD). The monomeric C- reactive protein (mCRP) formed in the dissociation of the pentraxin CRP within the extracellular matrix of ischemic tissue, may be a causative link between stroke-associated inflammation and memory loss. We aimed to investigate the mechanism underlying neuroinflammation and loss of neuroplasticity induced by mCRP. METHODS: We used our established in vivo model of dementia by bilateral hippocampus injection of mCRP in C57BL/6j mice. Transgenic AD mice 5XFAD were used for comparison. Cell lines of microglia BV2 and HMC3 and neuroblastoma SH-SY5Y were treated with mCRP or CRP. Microglial cells were also treated with lipopolysaccharide. We assayed hippocampus tissue and cell culture extracts for gene expression and protein levels in a search of changes underlying neuroinflammation, neuroplasticity loss and neurodegeneration. RESULTS: In vivo treatment with mCRP induced long-term loss of learning and memory, analyzed up to 6 months. First molecular results revealed lower activation of signaling pathways related to plasticity early genes Arc and Egr1 in mCRP mice. Main changes in 5XFAD were related to oxidative stress and gliosis markers. A main effect on protein processing induced by mCRP was hyperphosphorylation of tau in AD-associated pathogenic residues such as Ser202 and Ser396. We are analyzing the protective effects of anti-inflammatory agents. CONCLUSIONS: Characterizing the mechanisms of mCRP-induced dementia might contribute to fight against AD incidence in the elderly., EU-COP 2014-2020, CRP-SAD, ID: P_37_674, MySMIS code: 103432, contract: 51/05.09.2016; SAF2016‐77703, MINECO and ERDF; 2017-SGR-106, AGAUR.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Mechanisms of neuroprotection of soluble epoxide hydrolase enzyme inhibition in Alzheimer's disease models

  • Corpas, Rubén
  • Clotet Perarnau, Núria
  • Aguirre Infantes, Samuel
  • García-Lara, Elisa
  • Slevin, Mark
  • Griñán-Ferré, Christian
  • Galdeano, Carles
  • Vázquez, Santiago
  • Suñol, Cristina
  • Pallàs, Mercè
  • Sanfeliu, Coral
Trabajo presentado en el FENS Regional Meeting, celebrado en Belgrado (Sebia), del 10 al 13 de julio de 2019, Aim: Chronic neuroinflammation associated with aging contributes to the onset and progression of Alzheimer’s disease (AD). Epoxyeicosatrienoic acids (EETs) are endogenous mediators that have several protective functions including antiinflammatory effects. EETs beneficial effects diminish when the enzyme soluble epoxide hydrolase (sEH) metabolizes them to the corresponding dihydroxyeicosatrienoic acids. Previous results showed that sEH inhibition mitigates cognitive impairment and AD-like brain pathology in SAMP8 and 5XFAD mouse models of senescence and AD, respectively. Here we investigate the underlying mechanisms of neuroinflammation and proteostasis changes related to cognitive loss and its neuroprotection by sEH inhibitors. Methods: We used the known sEH inhibitor TPPU and the compound newly synthesized UB-EV-52. sEH inhibitors were administered through drinking water in the 5XFAD transgenic AD mouse models. In in vitro experiments, they were added to the media of microglia cell lines BV2 and HCM3, and neuroblastoma SH-SY5Y, previously treated with lipopolysaccharide or monomeric C- reactive protein as proinflammatory stimulus. As endpoints we analyzed inflammatory and survival pathways, and changes in proteostasis. Results: Our findings confirmed the beneficial effects of sEH inhibition, reducing the cognitive impairment, increase of proteolytic mechanism against aberrant proteins with decline of Aβ and tau pathology, and decrease of inflammatory markers that suggests a protection against inflammaging. Moreover, UB-EV-52 agent showed higher inhibitory potency than TPPU and no cytotoxicity. Conclusion: These results reinforce sEH as promising pharmacological target to fight against AD and other brain diseases that might be triggered by inflammaging processes, SAF2016‐77703, MINECO and ERDF; EU-COP 2014-2020, CRP-SAD, ID: P_37_674, MySMIS code: 103432, contract: 51/05.09.2016; 2017-SGR-106, AGAUR; Caixaimpuls 2018.